Ready to place a bet on a young, ambitious colt? Three such horses are lined up and ready to bolt out of the gate this week. Clinical-stage biopharma Actuate Therapeutics (ACTU) focuses on developing new therapeutics for cancer diseases. OneStream (OS) is an AI-enabled financial/operational platform for enterprise organizations. Lineage (LCTX) is a REIT (real estate investment trust) that operates a global network of 482 temperature-controlled warehouses in critical locations.

The IPO market is gaining momentum in 2024, with over $20 billion raised in the year's first half. This revival is attributed to moderating inflation and interest rates. IPOs are exciting but chancy. If you’re not risk-averse, consider these companies and prepare to hop aboard!

Actuate Therapeutics

Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company that aims to raise $25.3 million through its IPO, which will be listed on NASDAQ as “ACTU” on July 24. They will offer 2.78 million shares at $8-$10 each. The company will use this funding for working capital and to research, develop, and conduct clinical trials for its primary therapeutic candidate, Elraglusib. This new treatment is a novel glycogen synthase kinase-3β (GSK-3β) inhibitor, shown to have enormous potential in treating cancers, individually or combined with other therapies.

OneStream

OneStream, Inc. operates an enterprise-level finance platform using AI to unify operational and financial data. The company targets CFOs to enable them to drive business strategy and execution. OneStream’s IPO is scheduled for July 24, listing on the Nasdaq Global Select Market as “OS.” They will offer 24.5 million Class A shares at $17-$19 each, expecting to raise $362.6 million for various purposes. Part of the proceeds will be used to buy LLC Units of OneStream Software LLC, just issued, as well as issued and outstanding KKR & Co LLC Units.

Lineage

Lineage, Inc., a temperature-controlled warehouse REIT, is set to debut on the Nasdaq Global Select Market as "LINE" on July 25. The company is offering 47 million shares at $70-$82 each and aims to raise $3.9 billion to repay debts and redeem preferred stock. It has facilities across North America, Europe, and Asia-Pacific regions, and it provides clients with supply chain and technology solutions to boost distribution efficiency, minimize supply chain waste, and enhance sustainability.

Neither Julie Stoller nor Stocks.News have positions in any of the companies covered in this article.